Cite
HARVARD Citation
Brown, L. et al. (2021). Societal costs of primary progressive multiple sclerosis in Australia and the economic impact of a hypothetical disease-modifying treatment that could delay disease progression. Journal of medical economics. pp. 140-149. [Online].